ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Decay Accelerating Factor (DAF) Regulates Germinal Center B-cell and Alloantibody Formation

A. Cumpelik1, G. Varano2, D. Heja1, D. Homann3, S. Lira4, D. Dominguez-Sola2, P. S. Heeger1

1Nephrology, Mount Sinai School of Medicine, New York, NY, 2Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY, 3Medicine, Endocrinology, Diabetes and Bone Disease, Mount Sinai School of Medicine, New York, NY, 4Clinical Immunology, Mount Sinai School of Medicine, New York, NY

Meeting: 2019 American Transplant Congress

Abstract number: 168

Keywords: Alloantibodies, B cells, Mice, knockout, Sensitization

Session Information

Session Name: Concurrent Session: B-cell / Antibody /Autoimmunity

Session Type: Concurrent Session

Date: Sunday, June 2, 2019

Session Time: 4:30pm-6:00pm

 Presentation Time: 4:54pm-5:06pm

Location: Room 310

*Purpose: High affinity IgG antibodies including alloantibodies result from germinal center (GC) reactions in which somatic hypermutation and positive selection cause affinity maturation. When we compared cell surface molecule expression profiles of murine (A,B) and human naïve, memory and GC B cells we observed that GC B cells specifically lacked the complement regulator DAF, raising the possibility that DAF down-regulation on GC B cells is linked to GC function.

*Methods: To test this hypothesis, we constructed a mouse in which a transmembrane spanning form of DAF is conditionally overexpressed as a transgene (DAF-TM+/+) and crossed it to a Cgamma1 (Cg1) Cre-expressing mouse such that the DAF transgene is only expressed when B cells enter the GC (B).

*Results: Immunization with the model antigen NP or with allogeneic cells resulted in significantly reduced titers of antigen specific IgG by 3x fold in the DAF-TM+/+ animals vs. controls (C). Analyses of GCs confirmed DAF downregulation on control GC B cells but persistent DAF expression on DAF-TM+/+ mice (B), and demonstrated 3x fold fewer GC B cells by flow cytometry (D). Surface expression of other complement regulators and receptors, including CR2 known to be involved in B cell activation, did not differ between genotypes (E). Because DAF regulates C3 convertases and DAF deficiency augments C3a and C5a production, we tested whether C3a/C3aR and C5a/C5aR ligations on GC B cells is essential for their function. Flow cytometry showed that C3aR and C5aR expression are upregulated on GC B cells vs naïve B cells (F). We next generated mice conditionally deficient in both C3aR and C5aR, and crossed them to the Cg1-Cre mice such that both receptors are specifically deleted GC B cells. Absence of GC B cell C3aR/C5aR prevented antibody formation and markedly reduced GC B cell differentiation following immunization with NP (C,D) or allogeneic cells (G), newly demonstrating that C3aR/C5aR signaling on GC B cells is required for GC function.

*Conclusions: Together, our data show that DAF down-regulation on GC B cells facilitates C3aR/C5aR signaling required for GC function. In addition to delineating a paradigm shifting role for DAF and complement as regulators of GC dynamics, the findings have therapeutic implications for preventing and treating alloantibody formation in transplant recipients.

 border=

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Cumpelik A, Varano G, Heja D, Homann D, Lira S, Dominguez-Sola D, Heeger PS. Decay Accelerating Factor (DAF) Regulates Germinal Center B-cell and Alloantibody Formation [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/decay-accelerating-factor-daf-regulates-germinal-center-b-cell-and-alloantibody-formation/. Accessed May 16, 2025.

« Back to 2019 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences